The following report is a press release by Ceva Animal Health:
Ceva Animal Health (Ceva) – the #5th largest animal health global player, present in 110 countries, unveils its latest investment in European vaccine manufacturing, with the construction of a new facility in Hungary, expanding the capacity of Ceva Phylaxia.
Ceva Phylaxia, with over a century of expertise has been at the forefront of combating major livestock diseases through innovative research and vaccine development.
This development will establish a 7,000 m2 plant in Monor, Hungary withthe most advanced technologies,whereCeva will produce fermentation-based multicomponent inactivated vaccines for animals.
For over 20 years, Ceva has been a strong advocate for prevention through vaccination, heavily investing in preventive medicine to significantly improve the health of husbandries but also to fight zoonotic and emerging diseases, contributing to prepare for future pandemics.
Today, 54% of Ceva’s R&D budget is dedicated to vaccine development and the company already provides more than 50 vaccines to fight 19 zoonotic diseases.
Ceva is the most innovative animal health company in vaccine technologies and one of the leading players on a global scale. Ceva is the first and only company to have developed a mRNA platform for animals in less than three years, the historical world leader in vector vaccines for poultry, and remains the world leader in broiler vaccination and #1 in hatchery vaccination. The company has also extensive global expertise in autogenous vaccines.
With this investment, it will further strengthen its position, producing more than 8 billion doses of vaccines in this new manufacturing plant annually, on top of other animal health products.
“Building a new facility is always a significant milestone in the life of a company. In Hungary, we already benefit from a strong historical expertise with our Ceva Phylaxia campus. With the addition of this new production unit in Monor, we aim to create new synergies to advance preventive medicine. This project reflects our commitment to supporting farmers worldwide by developing tailored solutions to tackle emerging diseases and new variants. It embodies our ambition to build a promising future for our company, employees, and partners, both in Hungary and internationally, while strengthening our research and development capabilities.” says Marc Prikazsky, Chairman and CEO of Ceva Animal Health.
The new plant is scheduled to start operations at the end of 2026.
AUTHOR COMMENTARY
In September, I highlighted an article by Barron’s that declared we are experiencing the “golden age of vaccines,” and how vaccination is poised to play a bigger role in replacing traditional pharmaceuticals. Bill Gates said in 2021 that giant mRNA vaccine factories would be erected in preparation for “the next pandemic.”
Biotech firms are readying themselves for more rounds of scamdemics, and making a killing from it.
1 Timothy 6:10 For the love of money is the root of all evil: which while some coveted after, they have erred from the faith, and pierced themselves through with many sorrows.
[7] Who goeth a warfare any time at his own charges? who planteth a vineyard, and eateth not of the fruit thereof? or who feedeth a flock, and eateth not of the milk of the flock? [8] Say I these things as a man? or saith not the law the same also? [9] For it is written in the law of Moses, Thou shalt not muzzle the mouth of the ox that treadeth out the corn. Doth God take care for oxen? [10] Or saith he it altogether for our sakes? For our sakes, no doubt, this is written: that he that ploweth should plow in hope; and that he that thresheth in hope should be partaker of his hope. (1 Corinthians 9:7-10).
The WinePress needs your support! If God has laid it on your heart to want to contribute, please prayerfully consider donating to this ministry. If you cannot gift a monetary donation, then please donate your fervent prayers to keep this ministry going! Thank you and may God bless you.
